[HTML][HTML] Reliability of resting-state electrophysiology in fragile X syndrome
R Liu, EV Pedapati, LM Schmitt, RC Shaffer… - Biomarkers in …, 2023 - Elsevier
Abstract Objective Fragile X Syndrome (FXS) is the leading monogenic cause of intellectual
disability and autism spectrum disorder. Currently, there are no established biomarkers for …
disability and autism spectrum disorder. Currently, there are no established biomarkers for …
Sex differences during development in cortical temporal processing and event related potentials in wild-type and fragile X syndrome model mice
Background Autism spectrum disorder (ASD) is currently diagnosed in approximately 1 in 44
children in the United States, based on a wide array of symptoms, including sensory …
children in the United States, based on a wide array of symptoms, including sensory …
Aerobic Exercise Improves Cognitive Flexibility and Modulates Regional Volume Changes in a Rat Model of Autism
B Sivayokan, C King, I Mali, M Payne, H Strating… - Behavioural Brain …, 2024 - Elsevier
Gestational exposure to valproic acid (VPA) is a risk factor for autism spectrum disorder
(ASD). Rodents exposed to VPA in utero display common features of ASD, including …
(ASD). Rodents exposed to VPA in utero display common features of ASD, including …
The Effects of Pharmaceutical Intervention on Neural Connectivity and Complexity in Fragile X Syndrome
E Auger - 2023 - shareok.org
This study aims to investigate the effects of targeted pharmaceutical interventions on brain
networks in individuals with Fragile X Syndrome (FXS). Focusing on three drugs tested in …
networks in individuals with Fragile X Syndrome (FXS). Focusing on three drugs tested in …